Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 5
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
A hyperaldosteronism subtypes predictive model using ensemble learning.
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T; JPAS/JRAS Study Group. Karashima S, et al. Sci Rep. 2023 Feb 21;13(1):3043. doi: 10.1038/s41598-023-29653-2. Sci Rep. 2023. PMID: 36810868 Free PMC article.
Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
Kobayashi H, Nakamura Y, Abe M, Tanabe A, Sone M, Katabami T, Kurihara I, Ichijo T, Tsuiki M, Izawa S, Wada N, Yoneda T, Takahashi K, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Rakugi H, Naruse M; JPAS/JRAS Study Group. Kobayashi H, et al. Endocr J. 2023 May 29;70(5):489-500. doi: 10.1507/endocrj.EJ22-0585. Epub 2023 Mar 16. Endocr J. 2023. PMID: 36792218 Free article.
Diverse pathological lesions of primary aldosteronism and their clinical significance.
Nishimoto K, Umakoshi H, Seki T, Yasuda M, Araki R, Otsuki M, Katabami T, Shibata H, Ogawa Y, Wada N, Sone M, Okamura S, Izawa S, Miyauchi S, Yoshimoto T, Tsuiki M, Naruse M; JRAS Study Group. Nishimoto K, et al. Hypertens Res. 2021 May;44(5):498-507. doi: 10.1038/s41440-020-00579-w. Epub 2021 Jan 12. Hypertens Res. 2021. PMID: 33437027 Free PMC article.
Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Okamura S, Kai T, Izawa S, Yoshikawa Y, Yamada M, Chiba Y, Tanabe A, Naruse M; JPAS/JRAS Study Group. Haze T, et al. J Hum Hypertens. 2022 Oct;36(10):904-910. doi: 10.1038/s41371-021-00595-4. Epub 2021 Aug 30. J Hum Hypertens. 2022. PMID: 34462544
Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome.
Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo T, Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group. Kobayashi H, et al. Eur J Endocrinol. 2020 Mar;182(3):265-273. doi: 10.1530/EJE-19-0860. Eur J Endocrinol. 2020. PMID: 32038030
Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS/JRAS Study Group. Katabami T, et al. J Hypertens. 2019 Jul;37(7):1513-1520. doi: 10.1097/HJH.0000000000002070. J Hypertens. 2019. PMID: 31145370
Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism.
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Oki K, Kamemura K, Tanabe A, Naruse M; JPAS/JRAS study group. Nakamaru R, et al. Hypertension. 2021 Feb;77(2):537-545. doi: 10.1161/HYPERTENSIONAHA.120.16449. Epub 2020 Dec 28. Hypertension. 2021. PMID: 33356395
Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Watanabe M, Kamemura K, Okamura S, Tanabe A, Naruse M; JPAS/JRAS Study Group. Nakamaru R, et al. Sci Rep. 2021 Mar 25;11(1):6925. doi: 10.1038/s41598-021-86290-3. Sci Rep. 2021. PMID: 33767283 Free PMC article.
Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism.
Nakamaru R, Yamamoto K, Rakugi H, Akasaka H, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Okamoto R, Fujita M, Kobayashi H, Tamura K, Kamemura K, Okamura S, Kakutani M, Tanabe A, Naruse M; JPAS/JRAS Study Group. Nakamaru R, et al. Clin Endocrinol (Oxf). 2020 Sep;93(3):229-237. doi: 10.1111/cen.14203. Epub 2020 May 5. Clin Endocrinol (Oxf). 2020. PMID: 32324297
Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M; JPAS/JRAS Study Group. Ohno Y, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4382-4389. doi: 10.1210/jc.2018-02790. J Clin Endocrinol Metab. 2019. PMID: 31058960
16 results